— Know what they know.
Not Investment Advice

SWKHL NASDAQ

SWK Holdings Corporation 9.00% Senior Notes due 2027
1W: +0.1% 1M: +0.4% 3M: -0.6% YTD: -1.7% 1Y: +0.7% 3Y: +23.8%
$25.18
+0.01 (+0.06%)
 
Weekly Expected Move ±0.2%
$25 $25 $25 $25 $25
NASDAQ · Financial Services · Financial - Credit Services · Tech Score Neutral · Power 60 · $192.7M mcap · 11M float · 0.032% daily turnover · Short 47% of daily vol
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

18 relationships
18
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2021-06-29
Earliest Filing
2025-07-17
Latest Filing
customer: 8 partner: 6 acquirer: 2 target: 1 investor: 1

Counterparties (Filed by SWKHL)

18 relationships

Companies named in SWKHL's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
MOD3 Pharma Inc. — target Wholly owned subsidiary of SWK Holdings Corporation whose assets were sold to Aptar. 2025-07-17 View
AptarGroup, Inc. ATR acquirer Company that acquired MOD3 Pharma Inc.'s contract manufacturing, formulation and development services business. 2025-07-17 View
SCOF SPV I, LP — customer Purchaser of the Company's royalty portfolio rights 2025-04-10 View
Soleus Capital Management L.P. — partner Entity affiliated with the Purchaser SCOF SPV I, LP 2025-04-10 View
SWK Funding LLC — partner Wholly owned subsidiary of SWK Holdings Corporation involved in the royalty sale. 2025-03-20 View
SCOF SPV I, L.P. — acquirer Delaware limited partnership that purchased the Company's performing royalty portfolio. 2025-03-20 View
Soleus Capital Management L.P. — investor Entity affiliated with SCOF SPV I, L.P. involved in the royalty purchase. 2025-03-20 View
ANI Pharmaceuticals, Inc. ANIP customer Company that exercised a buy-back option for certain royalties payable to SWK Holdings Corporation. 2025-03-20 View
SWK Holdings Corporation SWKHL partner Issuer of the 9.00% Senior Notes due 2027 2023-10-03 View
Wilmington Trust, National Association — partner Trustee for the Indenture governing the Notes 2023-10-03 View
Cede & Co. — partner Nominee of DTC to whom Notes are issued 2023-10-03 View
BPM LLP — partner Independent registered public accounting firm that certified financial statements 2023-10-03 View
SWK HOLDINGS CORPORATION SWKHL customer Primary borrower in the loan and security agreement. 2022-11-22 View
SWK FUNDING LLC — customer Co-borrower in the loan and security agreement. 2022-11-22 View
SWK HOLDINGS CORPORATION SWKHL customer Borrower party to the Fourth Amendment to Loan and Security Agreement 2022-09-28 View
SWK FUNDING LLC — customer Borrower party to the Fourth Amendment to Loan and Security Agreement 2022-09-28 View
SWK HOLDINGS CORPORATION SWKHL customer Borrower party to the Second Amendment to Loan and Security Agreement 2021-06-29 View
SWK FUNDING LLC — customer Borrower party to the Second Amendment to Loan and Security Agreement 2021-06-29 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-04-06 Material Agreement; Termination of Agreement; Acquisition/Disposition; Delisting Notice; Change in C Agreement Acquisition View
2026-03-31 Shareholder Vote View
2026-02-13 Creation of Direct Financial Obligation View
2025-12-05 Creation of Direct Financial Obligation; Financial Statements and Exhibits View
2025-12-04 Other Events; Financial Statements and Exhibits View
2025-11-06 Results of Operations and Financial Condition View
2025-10-10 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-10-09 Other Events; Financial Statements and Exhibits View
2025-10-01 Other Events View
2025-08-14 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-07-17 Entry into Material Definitive Agreement Agreement View
2025-06-16 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-05-19 Other Events View
2025-05-15 Regulation FD Disclosure View
2025-05-15 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-10 Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure; Other Events; Financia Acquisition View
2025-03-20 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-20 Financial Statements and Exhibits View
2025-03-20 Entry into Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Statemen Agreement View
2024-11-15 Regulation FD Disclosure; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms